{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-06-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "13",
          "submission_status": "AP",
          "submission_status_date": "20130605",
          "submission_public_notes": "Please see <a href=\"https://www.fda.gov/STIC/\">www.fda.gov/STIC</a> for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "18335",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/065214s013lbl.pdf",
              "date": "20130611",
              "type": "Label"
            },
            {
              "id": "30655",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/065214Orig1s013ltr.pdf",
              "date": "20130606",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "5",
          "submission_status": "AP",
          "submission_status_date": "20080107",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20060310",
          "review_priority": "UNKNOWN",
          "submission_class_code": "UNKNOWN"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "16",
          "submission_status": "AP",
          "submission_status_date": "20190729",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "59504",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/065214Orig1s016ltr.pdf",
              "date": "20190730",
              "type": "Letter"
            },
            {
              "id": "59515",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/065214s016lbl.pdf",
              "date": "20190730",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20100222",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "18334",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/065214s008lbl.pdf",
              "date": "20100303",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "12",
          "submission_status": "AP",
          "submission_status_date": "20121212",
          "submission_class_code": "MANUF (CMC)",
          "submission_class_code_description": "Manufacturing (CMC)"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20100204",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "18333",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/065214s002lbl.pdf",
              "date": "20100216",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA065214",
      "sponsor_name": "B BRAUN",
      "openfda": {
        "application_number": [
          "NDA065214"
        ],
        "brand_name": [
          "CEFOXITIN AND DEXTROSE"
        ],
        "generic_name": [
          "CEFOXITIN SODIUM"
        ],
        "manufacturer_name": [
          "B. Braun Medical Inc."
        ],
        "product_ndc": [
          "0264-3123",
          "0264-3125"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "CEFOXITIN SODIUM"
        ],
        "rxcui": [
          "1665102",
          "1665107"
        ],
        "spl_id": [
          "0cca0e6a-3047-4142-af33-d9b98efe85b1"
        ],
        "spl_set_id": [
          "6c7e9485-1ede-411c-8c46-911439332864"
        ],
        "package_ndc": [
          "0264-3123-11",
          "0264-3125-11"
        ],
        "unii": [
          "Q68050H03T"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER",
          "active_ingredients": [
            {
              "name": "CEFOXITIN SODIUM",
              "strength": "EQ 1GM BASE/VIAL"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription",
          "te_code": "AP"
        },
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER",
          "active_ingredients": [
            {
              "name": "CEFOXITIN SODIUM",
              "strength": "EQ 2GM BASE/VIAL"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription",
          "te_code": "AP"
        }
      ]
    }
  ]
}